Overexpression of Transforming Growth Factor β1 in Head and Neck Epithelia Results in Inflammation, Angiogenesis, and Epithelial Hyperproliferation
- 1 July 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (13), 4405-4410
- https://doi.org/10.1158/0008-5472.can-04-1032
Abstract
In the present study, we show that transforming growth factor β1 (TGF-β1) was frequently overexpressed in human head and neck squamous cell carcinomas (HNSCCs) and adjacent tissues in comparison with normal head and neck tissues. To determine the role of TGF-β1 overexpression in HNSCC carcinogenesis, we generated transgenic mice in which TGF-β1 transgene expression can be induced in head and neck epithelia. TGF-β1 transgene induction in head and neck epithelia, at levels similar to those in human HNSCCs, caused severe inflammation and angiogenesis. Consequently, TGF-β1-transgenic epithelia exhibited hyperproliferation. These phenotypes correlated with enhanced Smad signaling in transgenic epithelia and stroma. Our study suggests that TGF-β1 overexpression at early stages of HNSCC formation provides a tumor promoting microenvironment.Keywords
This publication has 20 references indexed in Scilit:
- Activin Receptor-like Kinase (ALK)1 Is an Antagonistic Mediator of Lateral TGFβ/ALK5 SignalingMolecular Cell, 2003
- Reduced expression of transforming growth factor‐β receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinomaInternational Journal of Cancer, 2003
- Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outsJCI Insight, 2001
- Divergence and convergence of TGF‐β/BMP signalingJournal of Cellular Physiology, 2001
- NF-κB: a key role in inflammatory diseasesJCI Insight, 2001
- IntroductionMicrobes and Infection, 1999
- TGF-β and cancerMicrobes and Infection, 1999
- Cytokines in psoriasisInternational Journal of Dermatology, 1999
- REGULATION OF IMMUNE RESPONSES BY TGF-βAnnual Review of Immunology, 1998
- Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution.JCI Insight, 1990